|
Volumn 13, Issue 4, 2003, Pages 367-
|
Drug distribution and expenditure: The issue of Epoetin in Italy
d
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
RECOMBINANT ERYTHROPOIETIN;
ANEMIA;
CANCER CHEMOTHERAPY;
CLINICAL TRIAL;
DRUG COST;
DRUG DISTRIBUTION;
DRUG UTILIZATION;
HEALTH CARE COST;
HUMAN;
ITALY;
NOTE;
PRACTICE GUIDELINE;
PREVALENCE;
PRIORITY JOURNAL;
TREATMENT INDICATION;
TREATMENT OUTCOME;
ANEMIA;
DRUG COSTS;
DRUG INDUSTRY;
EPOETIN ALFA;
HEALTH EXPENDITURES;
HUMANS;
ITALY;
KIDNEY FAILURE, CHRONIC;
NATIONAL HEALTH PROGRAMS;
|
EID: 0347355040
PISSN: 11011262
EISSN: None
Source Type: Journal
DOI: 10.1093/eurpub/13.4.367 Document Type: Note |
Times cited : (5)
|
References (7)
|